An Immune-Competent Murine Model to Study Elimination of AAV-Transduced Hepatocytes by Capsid-Specific CD8(+) T Cells

Multiple independent adeno-associated virus (AAV) gene therapy clinical trials for hemophilia B, utilizing different AAV serotypes, have reported a vector dose-dependent loss of circulating factor IX (FIX) protein associated with capsid-specific CD8(+) T cell (Cap-CD8) elimination of transduced hepa...

Descripción completa

Detalles Bibliográficos
Autores principales: Palaschak, Brett, Marsic, Damien, Herzog, Roland W., Zolotukhin, Sergei, Markusic, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415329/
https://www.ncbi.nlm.nih.gov/pubmed/28480313
http://dx.doi.org/10.1016/j.omtm.2017.04.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415329/
https://www.ncbi.nlm.nih.gov/pubmed/28480313
http://dx.doi.org/10.1016/j.omtm.2017.04.004

Ejemplares similares